Population
Failing human hearts, hypertrophic murine hearts, transgenic mice with cardiac-specific IRF1 overexpression…
Comparison
Genetic overexpression or knockout of IRF1, and… vs Wild-type/control animals
Design
Preclinical
Authors
Loading...
IRF1-iNOS modulation should not yet inform heart failure care; leaves open its therapeutic relevance beyond murine pressure-overload models.
The IRF1-iNOS axis is a crucial regulator of pressure overload-induced cardiac remodeling, suggesting IRF1 as a potential therapeutic target for heart failure.
Jiang et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: